Nature Communications (May 2021)

Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas

  • M. Udugama,
  • L. Hii,
  • A. Garvie,
  • M. Cervini,
  • B. Vinod,
  • F.-L. Chan,
  • P. P. Das,
  • J. R. Mann,
  • P. Collas,
  • H. P. J. Voon,
  • L. H. Wong

DOI
https://doi.org/10.1038/s41467-021-22543-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Alternative Lengthening of Telomeres (ALT) is a telomere maintenance pathway utilised in 15% of cancers that have been associated with mutations in ATRX. Here the authors reveal a functional role of histone demethylases KDM4B in regulating ALT activation.